Mustafa Solak
- 4.6 優秀 • 217 レビュー
- 20年の経験
- トルコ, イスタンブール, Hisar Hospital Intercontinental
ムスタファ・ソラク医師は、ハジェテペ大学がん研究所でフェローシップ研修を修了し、胸腺腫症例を専門としています。
- 乳がん、肺がん、消化器がんの複雑な症例を担当
- テキサス大学MDアンダーソンがんセンターでの研修を修了
- 幅広いがんの診断および治療に豊富な経験を有する
- 続きを読む
ムスタファ・ソラク医師は、ハジェテペ大学がん研究所でフェローシップ研修を修了し、胸腺腫症例を専門としています。
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.
Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.
Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.
メリムスキー教授は、ソウラスキー医療センターの軟部組織・骨腫瘍ユニットを率い、胸腺腫治療において41年の経験以上の専門的経験を有しています。
Prof. Ralf Buhl is world famous neurosurgeon with over 20 years of experience. Doctor Buhl heads the Neurosurgery Department at Solingen Klinikum. His reputation reaches China and the US where he provides neurosurgical lectures.
Dr. Buhl specializes in non-invasive methods treatment of disc herniation, brain and spinal cord tumors. The doctor provides treatment of peripheral nervous system disorders and performs computer-assisted navigation microsurgeries.
Dr. Ralf Buhl has provided over 4,000 successful neurosurgeries. Among his patients are famous politicians, businessmen, musicians, actors. In 2015, a Hollywood star George Clooney had severe back pain and was treated by Professor Buhl.
Dr. Buhl conducts scientific work and researches in intracranial cavernomas treatment, surgical treatment for brain metastases and other neurosurgery areas.
Рrofessor Buhl has cofound the Fund devoted to the study of brain tumors.
ポートフォリオを見る
Education and Specialization
Work Experience
Expertise
Head of Teaching at the Puerto Vallarta Regional Hospital
2020-2023
Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020
General practitioner in private medical office
2015-2022
Doctor in charge of weight control clinic
2013-2014
Medical assistant in dermatology clinic
2008-2013
Medical Assistant in Dermatological procedures.
Medical Assistant in minimally invasive surgical procedures
Operation of fractional laser machine - IPIXEL-ER and
facial rejuvenation with IPL.
Experience in laser hair removal with Intense Pulsed Light and
radiofrequency
Experience with ultrasonic cavitation
Experience with ultraviolet (UV) light phototherapy machine for the
treatment of psoriasis and vitiligo.
Experience assisting in Botox and Fillers procedures.
Biomagnet certified by the Higher Institute of Biomagnetism
doctor ISAAC GOIZ DURAN
Experience in clinical records
Training in continuing education and professional development of teachers
Personal Information
Sex: Male
Born : 1968
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr 18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery. • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations
Personal information
Title: Professor Doctor
Branch: Radiation Oncology
Work History:
1 GATA Military Medical Faculty
2 Gayrettepe Florence Nightingale Hospital
3 T.R. Demiroğlu Bilim University \ Associate Professor
4 T.R Demiroğlu Bilim University \ Professor
Medical Specialties and Subspecialties:
1 Head and Neck Cancers
2 Radiation Oncology
Priority treatments:
1 Prostate cancer
2 Conformal treatments
Special advanced health technologies:
1 Truebeam Stx Technology
2 Halcyons
Education
1991 - Istanbul University Istanbul Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation
Oncology Specialization Training
Experience
2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital
2020 - 2021 Yüzüncü Yıl University Faculty of Medicine
2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.
2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department
2018 - 2021 Yüzüncü Yıl University Faculty of Medicine
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant
2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist
2012 - 2015 Suleiman the Magnificent Training and Research Hospital,
2008 - 2012 Haseki Training and Research Hospital
2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.
Education
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2007
Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi
Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).
He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.
He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.
Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.
Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.
Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.
He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.
アリ・ラファエル教授――テルアビブ・スラスキー医療センター(イキロフ、テルアビブ)トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。
資格および患者への貢献:
腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。
主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。
米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。
国際学術団体の会員(ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association)。最新の治療基準を活用し、国際的な研究に参画しています。
ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。
ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。
Education and Expertise
Selcuk University Meram Faculty of Medicine - Medical Education
Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization
Experience
Malatya State Hospital Internal Diseases Clinic
Ankara Oncology Hospital Medical Oncology Clinic
Erzurum Regional Training and Research Hospital Medical Oncology Clinic
AREAS OF INTEREST
Lung cancer
esophageal cancer
Gastric cancer
breast cancer
Gastrointestinal surgery
https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr
ツィエリンスキー教授はオーストリア最大の腫瘍科を率い、44年の経験以上にわたり現代のがん治療を牽引してきました。
Professor of oncosurgery and proctology
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 20年の経験 | 胸腺腫の治療 | フェローシップ研修を修了した専門医であり、MDアンダーソンがんセンターでの経験を有し、多種のがんを専門としています。 | トルコ | から $100 | |
| #2 | 41年の経験 | 複雑な胸部悪性腫瘍 | 希少胸部腫瘍および肉腫を専門とする。ESMO肉腫ファカルティメンバーとして治療プロトコルを開発。臨床診療とがん研究のリーダーシップを兼務する。 | イスラエル | から $950 | |
| #3 | 44年の経験 | 個別化がん免疫療法 | 個別化がん治療のパイオニアとして、腫瘍生物学に基づいた治療法を提供。ウィーン癌センターおよびウィーナー・プリバートクリニーク国際腫瘍センターを主導。 | オーストリア | お問い合わせください |